首页 › 基金 › Occam Crest Management LP › NVCT
Occam Crest Management LP 对 NVCT 的持仓历史
NUVECTIS PHARMA INC · 医疗保健
Occam Crest Management LP 在 Q3 2026 的 13F 申报中披露持有 NVCT(NUVECTIS PHARMA INC)2,800 股,市值约 US$3.1M,约占其申报组合的 1.75%,在其申报持仓中市值排名第 17 位。 Occam Crest Management LP 最近 5 个申报季度中有 5 个季度披露了 NVCT 持仓,最早可追溯至 Q3 2025。
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
Occam Crest Management LP 对 NVCT 的持仓演变
Occam Crest Management LP 于 Q3 2025 首次披露 NVCT 持仓:290,000 股(约 US$1.7M)。 该持仓在 Q2 2026 达到峰值 4,800 股,市值约 US$5.2M。 在 5 次申报中,Occam Crest Management LP 2 次增持、2 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 2,800 股、市值约 US$3.1M,环比减持 -2,000 股。。 持仓曾出现大幅变动:Q4 2025 增持约 31% (随后一个季度股价上涨 2%)、Q2 2026 减持约 99% (随后一个季度股价上涨 15%)、Q3 2026 减持约 42% (随后一个季度股价下跌 4%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2025 | 290.00K | $1.75M | 新进 |
| Q4 2025 | 380.00K | $2.87M | 增持 |
| Q1 2026 | 407.15K | $3.15M | 增持 |
| Q2 2026 | 4.80K | $5.16M | 减持 |
| Q3 2026 | 2.80K | $3.09M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 NVCT 与 13F 数据
NVCT(NUVECTIS PHARMA INC)属于医疗保健行业。我们追踪的基金中还有 63 只申报持有 NVCT,申报仓位最大的包括:TANG CAPITAL MANAGEMENT LLC (US$28.5M), Soleus Capital Management, L.P. (US$18.4M), IRIDIAN ASSET MANAGEMENT LLC/CT (US$16.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 NVCT 的基金
- TANG CAPITAL MANAGEMENT LLC 1.55M 股 · $28.50M · Q2 2026
- Soleus Capital Management, L.P. 1.00M 股 · $18.39M · Q2 2026
- IRIDIAN ASSET MANAGEMENT LLC/CT 793.21K 股 · $16.75M · Q3 2026
- BALDWIN WEALTH PARTNERS LLC/MA 382.01K 股 · $8.07M · Q3 2026
- SPHERA FUNDS MANAGEMENT LTD. 382.94K 股 · $7.04M · Q2 2026
- Avidity Partners Management LP 200.00K 股 · $3.68M · Q2 2026
- Squadron Capital Management LLC 38.70K 股 · $711.69K · Q2 2026
更多关于 Occam Crest Management LP
常见问题
How long has Occam Crest Management LP held NVCT?
Occam Crest Management LP has disclosed NVCT holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is Occam Crest Management LP's current position in NVCT?
As of Q3 2026, Occam Crest Management LP holds 2.80K shares of NVCT (NUVECTIS PHARMA INC), valued at $3.09M, representing 1.75% of its reported portfolio and ranking #17.
Has Occam Crest Management LP been buying or selling NVCT?
In the latest 13F filing (Q3 2026), Occam Crest Management LP reduced its position in NVCT. The position peaked in Q2 2026 at 4.80K shares.
Which other funds hold NVCT?
Other major institutional holders of NVCT include TANG CAPITAL MANAGEMENT LLC, Soleus Capital Management, L.P., IRIDIAN ASSET MANAGEMENT LLC/CT, among 63 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.